SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-058608
Filing Date
2022-11-23
Accepted
2022-11-23 16:05:35
Documents
1
Period of Report
2022-11-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3363
  Complete submission text file 0001209191-22-058608.txt   4964
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Issuer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ANELIXIS THERAPEUTICS, INC. 1500 DISTRICT AVENUE BURLINGTON MA 01803
Business Address
Perrin Steven (Reporting) CIK: 0001824545 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36620 | Film No.: 221416365